BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sun HC, Tang ZY. Preventive treatments for recurrence after curative resection of hepatocellular carcinoma - A literature review of randomized control trials. World J Gastroenterol 2003; 9(4): 635-640 [PMID: 12679900 DOI: 10.3748/wjg.v9.i4.635]
URL: https://www.wjgnet.com/1007-9327/full/v9/i4/635.htm
Number Citing Articles
1
Cindy J. Lai, Norah A. Terrault. Antiviral therapy in patients with chronic hepatitis B and cirrhosisGastroenterology Clinics of North America 2004; 33(3): 629 doi: 10.1016/j.gtc.2004.05.002
2
Christiane Kulinna, Wolfgang Schima. Focal Liver LesionsMedical Radiology 2005; : 275 doi: 10.1007/3-540-26354-3_19
3
Rinaldo Pellicano, Vincenzo Mazzaferro, Walter Franco Grigioni, Miguel Angel Cutufia, Sharmila Fagoonee, Lorenzo Silengo, Mario Rizzetto, Antonio Ponzetto. <i>Helicobacter</i> species sequences in liver samples from patients with and without hepatocellular carcinomaWorld Journal of Gastroenterology 2004; 10(4): 598-601 doi: 10.3748/wjg.v10.i4.598
4
Harufumi Maki, Kiyoshi Hasegawa. Advances in the surgical treatment of liver cancerBioScience Trends 2022; 16(3): 178 doi: 10.5582/bst.2022.01245
5
Yong-Song Guan, Qing He, Ming-Quan Wang. Transcatheter Arterial Chemoembolization: History for More than 30 YearsISRN Gastroenterology 2012; 2012: 1 doi: 10.5402/2012/480650
6
Ignacio García-Alonso, Teodoro Palomares, Ana Alonso, Miguel Echenique-Elizondo, Juan Caramés, Begonia Castro, Jaime Méndez. Effect of Liver Resection on the Progression and Growth of Rhabdomyosarcoma Metastases in a Rat ModelJournal of Surgical Research 2008; 148(2): 185 doi: 10.1016/j.jss.2007.06.026
7
Renumathy Dhanasekaran, Roniel Cabrera. Primary Liver Cancer2012; : 263 doi: 10.1007/978-1-61779-863-4_14
8
Ronnie T.P. Poon. Prevention of recurrence after resection of hepatocellular carcinoma: A daunting challengeHepatology 2011; 54(3): 757 doi: 10.1002/hep.24569
9
Elshazly Sheta, Ferial El-Kalla, Mohamed El-Gharib, Abdelrahman Kobtan, Mohammed Elhendawy, Sherief Abd-Elsalam, Loai Mansour, Ibrahim Amer. Comparison of single-session transarterial chemoembolization combined with microwave ablation or radiofrequency ablation in the treatment of hepatocellular carcinoma: a randomized-controlled studyEuropean Journal of Gastroenterology & Hepatology 2016; 28(10): 1198 doi: 10.1097/MEG.0000000000000688
10
Zhendong Gao, Gang Du, Yuguang Pang, Zhihao Fu, Chongzhong Liu, Yi Liu, Binghai Zhou, Du Kong, Binyao Shi, Zhengcheng Jiang, Bin Jin. Adjuvant transarterial chemoembolization after radical resection contributed to the outcomes of hepatocellular carcinoma patients with high-risk factorsMedicine 2017; 96(33): e7426 doi: 10.1097/MD.0000000000007426
11
Shi-Min Luo, Li-Jian Liang, Jia-Ming Lai. Effects of recombinant human growth hormone on remnant liver after hepatectomy in hepatocellular carcinoma with cirrhosisWorld Journal of Gastroenterology 2004; 10(9): 1292-1296 doi: 10.3748/wjg.v10.i9.1292
12
Tae-Jin Song, Edmund Wai Kit Ip, Yuman Fong. Hepatocellular carcinoma: Current surgical managementGastroenterology 2004; 127(5): S248 doi: 10.1053/j.gastro.2004.09.039
13
Changlie Zhang, Zhihong Song, Guangji Yu. High Expression of Parkin Predicts Easier Recurrence of Patients With Adjuvant Transarterial ChemoembolizationBiomarkers in Medicine 2017; 11(10): 823 doi: 10.2217/bmm-2017-0129
14
Mohamed Abdel-Wahab, Tarek Salah El-Husseiny, Ehab El Hanafy, Mohamed El Shobary, Emad Hamdy. Prognostic factors affecting survival and recurrence after hepatic resection for hepatocellular carcinoma in cirrhotic liverLangenbeck's Archives of Surgery 2010; 395(6): 625 doi: 10.1007/s00423-010-0643-0
15
Jill Allen, Alan Venook. Hepatocellular carcinoma: Epidemic and treatmentCurrent Oncology Reports 2004; 6(3): 177 doi: 10.1007/s11912-004-0047-9
16
Donghe Chen, Chengdong Chang, Yafei Zhang, Shuye Yang, Guolin Wang, Lili Lin, Xin Zhao, Kui Zhao, Xinhui Su. Different Features of 18F-FAPI, 18F-FDG PET/CT and MRI in the Evaluation of Extrahepatic Metastases and Local Recurrent Hepatocellular Carcinoma (HCC): A Case Report and Review of the LiteratureCancer Management and Research 2022; : 2649 doi: 10.2147/CMAR.S374916
17
Valerie Fako, Xin Wei Wang. The status of transarterial chemoembolization treatment in the era of precision oncologyHepatic Oncology 2017; 4(2): 55 doi: 10.2217/hep-2017-0009
18
Shi-Ying Xuan, Yong-Ning Xin, An-Jin Chen, Quan-Jiang Dong, Xin Qiang, Ning Li, Ming-Hua Zheng, Hua-Shi Guan. Association between the presence of <italic>H pylori</italic> in the liver and hepatocellular carcinoma: A meta-analysisWorld Journal of Gastroenterology 2008; 14(2): 307-312 doi: 10.3748/wjg.14.307
19
Jian‐Hong Zhong, Le‐Qun Li. Postoperative adjuvant transarterial chemoembolization for participants with hepatocellular carcinoma: A meta‐analysisHepatology Research 2010; 40(10): 943 doi: 10.1111/j.1872-034X.2010.00710.x
20
Zhan Hua, Jingzhou Chen, Baishun Sun, Gonghua Zhao, Yuanchun Zhang, Yuman Fong, Zhengeng Jia, Li Yao. Specific expression of osteopontin and S100A6 in hepatocellular carcinomaSurgery 2011; 149(6): 783 doi: 10.1016/j.surg.2010.12.007
21
Ulrich-Frank Pape, Thomas Berg, Bertram Wiedenmann. Medizinische Therapie 2005|20062005; : 837 doi: 10.1007/3-540-27385-9_77
22
Shi-Ying Xuan, Ning Li, Xin Qiang, Rong-Rong Zhou, Yong-Xin Shi, Wen-Jie Jiang. Helicobacter infection in hepatocellular carcinoma tissueWorld Journal of Gastroenterology 2006; 12(15): 2335-2340 doi: 10.3748/wjg.v12.i15.2335
23
Roberto Santambrogio, Enrico Opocher, Massimo Zuin, Carlo Selmi, Emanuela Bertolini, Mara Costa, Matteo Conti, Marco Montorsi. Surgical Resection Versus Laparoscopic Radiofrequency Ablation in Patients With Hepatocellular Carcinoma and Child-Pugh Class A Liver CirrhosisAnnals of Surgical Oncology 2009; 16(12): 3289 doi: 10.1245/s10434-009-0678-z
24
Xiyang Wei, Lei Zhao, Ruizhe Ren, Fubo Ji, Shuting Xue, Jianjuan Zhang, Zhaogang Liu, Zhao Ma, Xin W. Wang, Linda Wong, Niya Liu, Jiong Shi, Xing Guo, Stephanie Roessler, Xin Zheng, Junfang Ji. MiR‐125b Loss Activated HIF1α/pAKT Loop, Leading to Transarterial Chemoembolization Resistance in Hepatocellular CarcinomaHepatology 2021; 73(4): 1381 doi: 10.1002/hep.31448
25
Ming-Chih Ho, Jen-Jen Lin, Chiung-Nien Chen, Chaur-Chin Chen, Hsinyu Lee, Ching-Yao Yang, Yen-Hsuan Ni, King-Jen Chang, Hey-Chi Hsu, Fon-Jou Hsieh, Po-Huang Lee. A Gene Expression Profile for Vascular Invasion can Predict the Recurrence After Resection of Hepatocellular Carcinoma: a Microarray ApproachAnnals of Surgical Oncology 2006; 13(11): 1474 doi: 10.1245/s10434-006-9057-1
26
S G Lee, S Hwang, J P Jung, Y J Lee, K H Kim, C S Ahn. Outcome of patients with huge hepatocellular carcinoma after primary resection and treatment of recurrent lesionsBritish Journal of Surgery 2007; 94(3): 320 doi: 10.1002/bjs.5622
27
Hae-Na Shin, Shin Hwang, Ki-Hun Kim, Chul-Soo Ahn, Deok-Bog Moon, Tae-Yong Ha, Gi-Won Song, Young-Joo Lee, Sung-Gyu Lee. Role of the 1-month protocol transarterial chemoinfusion in detecting intrahepatic metastasis after resection of large hepatocellular carcinoma greater than 10 cmKorean Journal of Hepato-Biliary-Pancreatic Surgery 2013; 17(4): 157 doi: 10.14701/kjhbps.2013.17.4.157
28
Yong‐Bing Qian, Ju‐Bo Zhang, Wei‐Zhong Wu, Hong‐Bin Fang, Wei‐Dong Jia, Peng‐Yuan Zhuang, Bo‐Heng Zhang, Qi Pan, Yang Xu, Lu Wang, Zhao‐You Tang, Hui‐Chuan Sun. P48 is a predictive marker for outcome of postoperative interferon‐α treatment in patients with hepatitis B virus infection‐related hepatocellular carcinomaCancer 2006; 107(7): 1562 doi: 10.1002/cncr.22206
29
Qiang YAN, Jun NI, Guo-lei ZHANG, Xing YAO, Wen-bin YUAN, Lin ZHOU, Shu-sen ZHENG. Efficacy of postoperative antiviral combined transcatheter arterial chemoembolization therapy in prevention of hepatitis B-related hepatocellular carcinoma recurrenceChinese Medical Journal 2013; 126(5): 855 doi: 10.3760/cma.j.issn.0366-6999.20121871
30
Zheng-Gang Ren, Zhi-Ying Lin, Jing-Lin Xia, Sheng-Long Ye, Zeng-Chen Ma, Qing-Hai Ye, Lun-Xiu Qin, Zhi-Quan Wu, Jia Fan, Zhao-You Tang. Postoperative adjuvant arterial chemoembolization improves survival of hepatocellular carcinoma patients with risk factors for residual tumor: A retrospective control studyWorld Journal of Gastroenterology 2004; 10(19): 2791-2794 doi: 10.3748/wjg.v10.i19.2791
31
N. Girard, F. Mornex, C. Trepo, P. Merle. Place de la radiothérapie dans la stratégie de traitement du carcinome hépatocellulaireOncologie 2007; 9(6): 482 doi: 10.1007/s10269-007-0650-0
32
Tianhao Cong, Chao Yang, Qi Cao, Jinrui Ren, Yingen Luo, Pei Yuan, Bo Zheng, Yu Liu, Hongcai Yang, Wendi Kang, Aixin Ou, Xiao Li. The Role of GNMT and MMP12 Expression in Determining TACE Efficacy: Validation at Transcription and Protein LevelsJournal of Hepatocellular Carcinoma 2024; : 95 doi: 10.2147/JHC.S441179
33
Rong‐Xin Chen, Yun‐Hong Xia, Jie‐Feng Cui, Tong‐Chun Xue, Sheng‐Long Ye. Osteopontin, a single marker for predicting the prognosis of patients with tumor‐node‐metastasis stage I hepatocellular carcinoma after surgical resectionJournal of Gastroenterology and Hepatology 2010; 25(8): 1435 doi: 10.1111/j.1440-1746.2010.06277.x
34
John F Perry, Simone I Strasser, Jacob George, Geoffrey C Farrell, Geoffrey W McCaughan. Pharmacotherapy of hepatocellular carcinomaExpert Opinion on Pharmacotherapy 2003; 4(12): 2175 doi: 10.1517/14656566.4.12.2175
35
Zhaoyou Tang. Primary Liver Cancer2012; : 367 doi: 10.1007/978-3-642-28702-2_12
36
Zhao-You Tang, Lun-Xiu Qin. Cancer Metastasis2011; : 344 doi: 10.1017/CBO9780511976117.034
37
Mindie H. Nguyen, Emmet B. Keeffe. General managementBest Practice & Research Clinical Gastroenterology 2005; 19(1): 161 doi: 10.1016/j.bpg.2004.11.001
38
Beatrice Gerard, Harry Bleiberg. Treatment of hepatocarcinomaCurrent Oncology Reports 2004; 6(3): 184 doi: 10.1007/s11912-004-0048-8
39
Hui-Chuan Sun. Liver Cancer2009; : 303 doi: 10.1007/978-1-4020-9804-8_23
40
Yongqiang Zhan, Lisha Mou, Kangwen Cheng, Chengyou Wang, Xuesong Deng, Junren Chen, Zhibing Fan, Yong Ni. Hepatocellular carcinoma stem cell-like cells are enriched following low-dose 5-fluorouracil chemotherapyOncology Letters 2016; 12(4): 2511 doi: 10.3892/ol.2016.4975
41
Zhixiong Cai, Xiaoping Su, Liman Qiu, Zhenli Li, Xiaolou Li, Xiuqing Dong, Fuqun Wei, Yang Zhou, Liuping Luo, Geng Chen, Hengkai Chen, Yingchao Wang, Yongyi Zeng, Xiaolong Liu. Personalized neoantigen vaccine prevents postoperative recurrence in hepatocellular carcinoma patients with vascular invasionMolecular Cancer 2021; 20(1) doi: 10.1186/s12943-021-01467-8
42
Azzaroli Francesco, Accogli Esterita, Nigro Giovanni, Trer&egrave; Davide, Giovanelli Silvia, Miracolo Anna, Lodato Francesca, Montagnani Marco, Tam&eacute; Mariarosa, Colecchia Antonio, Mwangemi Constance, Festi Davide, Roda Enrico, Derenzini Massimo, Mazzella Giuseppe. Interferon plus ribavirin and interferon alone in preventing hepatocellular carcinoma: A prospective study on patients with HCV related cirrhosisWorld Journal of Gastroenterology 2004; 10(21): 3099-3102 doi: 10.3748/wjg.v10.i21.3099
43
O. Aysun, A. Aysegul, F. Kayahan. Combined effect of epirubicin and lymphokine-activated killer cells on the resistant human breast cancer cellsCell Biology and Toxicology 2004; 20(5): 261 doi: 10.1007/s10565-004-3471-6
44
Xiaohong Chen, Boheng Zhang, Xin Yin, Zhenggang Ren, Shuangjian Qiu, Jian Zhou. Lipiodolized transarterial chemoembolization in hepatocellular carcinoma patients after curative resectionJournal of Cancer Research and Clinical Oncology 2013; 139(5): 773 doi: 10.1007/s00432-012-1343-7
45
Maurizio Chiriva-Internati, Fabio Grizzi, Cynthia A Jumper, Everardo Cobos, Paul L Hermonat, Eldo E Frezza. Immunological treatment of liver tumorsWorld Journal of Gastroenterology 2005; 11(42): 6571-6576 doi: 10.3748/wjg.v11.i42.6571
46
Lian Li, Bo Li, Ming Zhang. Postoperative adjuvant transarterial chemoembolization improves the prognosis of hepatocellular carcinoma patients with microvascular invasion: a systematic review and meta-analysisActa Radiologica 2020; 61(6): 723 doi: 10.1177/0284185119878357
47
Shigeki Nakagawa, Yo-ichi Yamashita, Naoki Umezaki, Takanobu Yamao, Takayoshi Kaida, Yukiharu Hiyoshi, Kosuke Mima, Hirohisa Okabe, Hiromitsu Hayashi, Katsunori Imai, Akira Chikamoto, Hideo Baba. Four gene intrahepatic metastasis–risk signature predicts hepatocellular carcinoma malignant potential and early recurrence from intrahepatic metastasisSurgery 2021; 169(4): 903 doi: 10.1016/j.surg.2020.09.032
48
Jian-Min Qin. Postoperative recurrent factors and therapeutic and preventive strategies for hepatocellular carcinomaWorld Chinese Journal of Digestology 2019; 27(23): 1407 doi: 10.11569/wcjd.v27.i23.1407
Abstract() |  Core Tip() |  Full Article(HTML)() | Times Cited  (0) | Total Visits (0) | Open
49
Liming Wang, Weihu Wang, Xuesong Yao, Weiqi Rong, Fan Wu, Bo Chen, Mei Liu, Shengtao Lin, Yunhe Liu, Jianxiong Wu. Postoperative adjuvant radiotherapy is associated with improved survival in hepatocellular carcinoma with microvascular invasionOncotarget 2017; 8(45): 79971 doi: 10.18632/oncotarget.20402
50
Ulrich-Frank Pape, Thomas Berg, Bertram Wiedenmann. Medizinische Therapie 2007 | 20082007; : 921 doi: 10.1007/978-3-540-48554-4_77
51
Jian-Hong Zhong, Liang Ma, Le-Qun Li. Postoperative therapy options for hepatocellular carcinomaScandinavian Journal of Gastroenterology 2014; 49(6): 649 doi: 10.3109/00365521.2014.905626
52
Jun-Gong Zhao, Gan-Sheng Feng, Xiang-Quan Kong, Xin Li, Ming-Hua Li, Ying-Sheng Cheng. Assessment of hepatocellular carcinoma vascularity before and after transcatheter arterial chemoembolization by using first pass perfusion weighted MR imagingWorld Journal of Gastroenterology 2004; 10(8): 1152-1156 doi: 10.3748/wjg.v10.i8.1152